Discovery of a novel dual-targeting D-peptide to block CD24/Siglec-10 and PD-1/PD-L1 interaction and synergize with radiotherapy for cancer immunotherapy.
Wenhui ShenPeishang ShiQingyu DongXiuman ZhouChunxia ChenXinghua SuiWentong TianXueqin ZhuXiaoxi WangShengzhe JinYahong WuGuanyu ChenLu QiuWenjie ZhaiYan-Feng GaoPublished in: Journal for immunotherapy of cancer (2023)
T cells for cancer immunotherapy.